Estíbaliz Jarauta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Estíbaliz Jarauta has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Fernando Civeira
Instituto de Investigación Sanitaria Aragón (IIS Aragón), Hospital Universitario Miguel Servet, Zaragoza, Spain; Consortium for Biomedical Research (CIBERCV, CIBERESP, CIBEREHD or CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain; Departamento de Medicina, Psiquiatría y Dermatología, Facultad de Medicina, Universidad de Zaragoza, Zaragoza, Spain
3 shared publications - Emilio Ros
Institut d’Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Hospital Clínic de Barcelona, Rosselló 149, 08036 Barcelona, Spain
2 shared publications - Itziar Lamiquiz-Moneo
Hospital Universitario Miguel Servet, Instituto de Investigación Sanitaria Aragón (IIS Aragón), CIBERCV, Zaragoza, Spain
2 shared publications - Victoria Marco-Benedí
Unidad Clínica y de Investigación en Lípidos y Arteriosclerosis, Hospital Universitario Miguel Servet, Instituto de Investigación Sanitaria Aragón (IIS Aragón), Zaragoza. Centro de Investigación Biomédica en Red Cardiovascular (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain (Drs Gracia-Rubio, Lamiquiz-Moneo, Bea, Marco-Benedí, Civeira, and Cenarro); Universidad de Zaragoza, Zaragoza, Spain (Drs Gracia-Rubio, Lamiquiz-Moneo, Marco-Benedí, and Civeira)
2 shared publications Ana Cenarro
Lipid Unit, Hospital Universitario Miguel Servet, IIS Aragón, CIBERCV, Universidad de Zaragoza, Zaragoza, Spain
1 shared publication- Ana Cenarro
Unidad Clínica y de Investigación en Lípidos y Arteriosclerosis, Hospital Universitario Miguel Servet, Instituto de Investigación Sanitaria Aragón (IIS Aragón), Zaragoza. Centro de Investigación Biomédica en Red Cardiovascular (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain (Drs Gracia-Rubio, Lamiquiz-Moneo, Bea, Marco-Benedí, Civeira, and Cenarro); Instituto Aragonés de Ciencias de la Salud (IACS), Zaragoza, Spain (Dr Cenarro)
1 shared publication
Latest Publications
- Open Access
- 1 March 2019
- Published by Elsevier in Atherosclerosis
- Vol. 282, 143-147
Lipid-lowering response in subjects with the p.(Leu167del) mutation in the APOE gene
- 1 March 2019
- Published by Elsevier in Atherosclerosis
- Vol. 282, 143-147
Open AccessLipid-lowering response in subjects with the p.(Leu167del) mutation in the APOE gene
- 1 December 2009
- Published by Springer Nature in Journal of Physiology and Biochemistry
- Vol. 65 (4) , 397-404
A moderate intake of phytosterols from habitual diet affects cholesterol metabolism
Cholesterol metabolism homeostasis is the result of a balance between synthesis, degradation and intestinal absorption. It is well established that intestinal cholesterol absorption efficiency can be modified by the intake of phytosterol-enriched food and, therefore, have a serum cholesterol-lowering effect. Recent epidemiological and clinical studies have shown that presence of phytosterols at normal diet levels could also be effective on lowering total and LDL serum cholesterol since they affect whole-body cholesterol metabolism even at those moderate doses. The aim of this study was to analyze the effect of the levels of the naturally-occurring phytosterols in the diet on cholesterol metabolism parameters. In order to do that a group of 99 healthy volunteers was studied for their dietary habits and surrogate markers of cholesterol synthesis and absorption. The mean daily dietary intake of phytosterols, measured by a food semiquantitative frequency questionnaire, was found to be 494 mg being β-sitosterol the major contributor to it. Subjects were classified into tertiles according to their total phytosterol intake and comparisons were done between subgroups. No statistical differences were observed for surrogate markers of intestinal cholesterol absorption, but a significant increase in the cholesterol synthesis surrogate marker lathosterol-to-cholesterol ratio associated to highest dietary phytosterol intake was observed. Regardless of this, only a non significant trend toward a less atherogenic lipid profile was observed in the upper tertile. In conclusion, the intake of moderate amounts of phytosterols naturally present in habitual diet may affect cholesterol metabolism and specially the rate of cholesterol synthesis as estimated by the surrogate marker lathosterol-to-cholesterol ratio in serum.
- 1 December 2009
- Published by Springer Nature in Journal of Physiology and Biochemistry
- Vol. 65 (4) , 397-404
A moderate intake of phytosterols from habitual diet affects cholesterol metabolism
Cholesterol metabolism homeostasis is the result of a balance between synthesis, degradation and intestinal absorption. It is well established that intestinal cholesterol absorption efficiency can be modified by the intake of phytosterol-enriched food and, therefore, have a serum cholesterol-lowering effect. Recent epidemiological and clinical studies have shown that presence of phytosterols at normal diet levels could also be effective on lowering total and LDL serum cholesterol since they affect whole-body cholesterol metabolism even at those moderate doses. The aim of this study was to analyze the effect of the levels of the naturally-occurring phytosterols in the diet on cholesterol metabolism parameters. In order to do that a group of 99 healthy volunteers was studied for their dietary habits and surrogate markers of cholesterol synthesis and absorption. The mean daily dietary intake of phytosterols, measured by a food semiquantitative frequency questionnaire, was found to be 494 mg being β-sitosterol the major contributor to it. Subjects were classified into tertiles according to their total phytosterol intake and comparisons were done between subgroups. No statistical differences were observed for surrogate markers of intestinal cholesterol absorption, but a significant increase in the cholesterol synthesis surrogate marker lathosterol-to-cholesterol ratio associated to highest dietary phytosterol intake was observed. Regardless of this, only a non significant trend toward a less atherogenic lipid profile was observed in the upper tertile. In conclusion, the intake of moderate amounts of phytosterols naturally present in habitual diet may affect cholesterol metabolism and specially the rate of cholesterol synthesis as estimated by the surrogate marker lathosterol-to-cholesterol ratio in serum.
- 1 May 2008
- Published by Elsevier in Atherosclerosis Supplements
- Vol. 9 (1) , 112-113
IMPACT OF LOW-DENSITY LIPOPROTEIN RECEPTOR (LDLR) MUTATIONAL CLASS ON CAROTID ATHEROSCLEROSIS IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA (FH)
- 1 May 2008
- Published by Elsevier in Atherosclerosis Supplements
- Vol. 9 (1) , 112-113
IMPACT OF LOW-DENSITY LIPOPROTEIN RECEPTOR (LDLR) MUTATIONAL CLASS ON CAROTID ATHEROSCLEROSIS IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA (FH)